3,252 hedge funds and large institutions have $222B invested in Pfizer in 2021 Q4 according to their latest regulatory filings, with 586 funds opening new positions, 1,251 increasing their positions, 1,152 reducing their positions, and 85 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding:

9% more repeat investments, than reductions

Existing positions increased: 1,251 | Existing positions reduced: 1,152

1% more call options, than puts

Call options by funds: $5.34B | Put options by funds: $5.26B

0.97% more ownership

Funds ownership: 66.27%67.24% (+0.97%)

Holders
3,252
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
249
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$5.34B
Puts
$5.26B
Net Calls
Net Calls Change

Top Buyers

1 +$610M
2 +$609M
3 +$455M
4
JP Morgan Chase
JP Morgan Chase
New York
+$375M
5
Two Sigma Advisers
Two Sigma Advisers
New York
+$323M
Name Holding Trade Value Shares
Change
Change in
Stake
1326
$3.13M
1327
$3.13M
1328
$3.12M
1329
$3.11M
1330
$3.1M
1331
$3.1M
1332
$3.09M
1333
$3.09M
1334
$3.08M
1335
$3.08M
1336
$3.08M
1337
$3.08M
1338
$3.07M
1339
$3.07M
1340
$3.07M
1341
$3.06M
1342
$3.06M
1343
$3.06M
1344
$3.06M
1345
$3.06M
1346
$3.05M
1347
$3.05M
1348
$3.05M
1349
$3.04M
1350
$3.03M